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#Corresponding author.(4.8%). Pain, having both physiological and psychological com-
ponents, was also included and is the most common condition
treated at IM clinics. Those with high stress, psychological
conditions, and pain were most frequently treated with acupunc-
ture, IM physician consultation, exercise, chiropractic services,
diet/nutrition counseling, and massage.
Conclusion: With baseline information on clinical presenta-
tion and service utilization, future PBRN studies can examine
promising interventions delivered at the clinic to treat stress
and psychological conditions.
Key words: Integrative medicine, PBRN, stress, psychological
disorders, painINTRODUCTION
While integrative medicine (IM) therapies have demonstrated
efficacy for numerous physiological conditions,1,2 IMapproaches for psychological conditions, including affective
disorders, have not been as well accepted by the medical
community.3,4 Despite IM provider reports of success treating
psychological conditions5 and growth in high-quality research
on IM for treating stress, other psychological conditions, and
pain,6,7 there is yet to be substantial practice-based data
available to guide clinicians in pairing psychological condi-
tions, particularly affective disorders, with appropriate IM
therapies.
IM is a rapidly growing field aimed at optimizing health
and wellness while addressing core causes of illness through
personalized care.8 Although IM combines evidence-based
Western and non-Western therapies, IM is not simply a blend
of complementary and alternative medicine (CAM) and
conventional medicine; rather, it is a complex system of care
that emphasizes prevention, wellness, and bio-psycho-socio-
spiritual healing of the whole person to support the body's
innate healing abilities.9,10 As consumer interest grows in
complementary therapies used in IM,11 so does the
prevalence of IM clinics in academic medical centers and
health systems. Despite this, research is limited on the
practice-based applicability and effectiveness of IM, partic-
ularly regarding psychological symptoms.12
Psychological issues such as stress, depressive symptoms,
fatigue, chronic pain, and disordered sleep affect multiple
body systems, lifestyle choices, morbidity, and mortality.13–18
Because stress responses can impact multiple systems,19 it is
not surprising that an estimated 60–90% of physician visits
are stress related.20,21 One particularly helpful aspect of IM
treatment lies in its ability to positively impact multiple
physiologic systems simultaneously. For example, the use of
acupuncture and meditation to treat chronic stress simulta-
neously impacts a plethora of systems including the auto-
nomic nervous system, musculoskeletal, cardiovascular,
immune, and endocrine systems.
Practice-based research networks (PBRNs) have emerged as
an effective means to connect researchers and clinicians in the
clinical setting to systematically collect data about typical
practices and clinical effectiveness.22–24 BraveNet, the first IM
PBRN, has conducted two studies to better understand
patients seeking and receiving IM. In one study,25 mean
pain-severity scores for 252 IM chronic-pain patients
decreased 23% from moderate to mild, and pain interference
scores dropped 28% over six months of IM care. Also, IM
treatment positively impacted other psychological outcomes.
The goal of this article is to systematically characterize the
psychological profile of patients seeking care at IM clinics and
the integrative services provided to those presenting with
psychological issues.METHODS
Participants and Procedures
A total of 4182 patients were recruited from nine IM clinics
that comprise the BraveNet PBRN (Table S1). Eligible
participants were Z18 years old, English- or Spanish-
literate, able and willing to provide informed consent, and
receiving treatment by an IM clinician. Participants
completed a uniform set of questionnaires, within two
weeks of their IM clinic visit. A corresponding form was
completed by the clinician (or research staff using the medical
record) to indicate provider assessment of conditions that
were addressed and IM services that were provided. Site-
research personnel entered de-identified data into a central
database through a secure website. All procedures for each
study center and the coordinating center received full appro-
val by the appropriate institutional review boards (IRBs).a
Measures
Participants were provided a case report form, which included
basic demographic information and three well-validated
psychological questionnaires. Perception of stress level was
determined via the four-item Perceived Stress Scale (PSS-426).
PSS-4 scores range from 0 to 16, with a national average of 4.4a Full approval for the study was received by Allina Health IRB;
Beth Israel Medical Center Human Subjects Protection Office IRB;
Duke University Health Systems IRB; The Scripps Clinic IRB;
Thomas Jefferson University, Division of Human Subjects Protec-
tion; University of California Los Angeles IRB; University of
California San Francisco Committee on Human Research; and
University of Maryland IRB. The BraveNet Network Coordinating
and Statistical Center first received IRB approval through Duke
University Health System (Protocol #18346) in 2008 and has
maintained this approval through the present.[standard deviation (SD) ¼ 2.9] for individuals aged 45–54
years.27 Mood was assessed via the 10-item Center for
Epidemiologic Studies Depression Scale (CESD28), for
which scores range from 0 to 30.29 Quality of life was
assessed using the 12-Item Short Form Health Survey (SF-
12) to obtain both physical and mental function estimates.30
US physical-health norms have a mean of 50 (SD ¼ 9.6), and
mental-health norms have a mean of 50 (SD ¼ 9.531).
Participants indicated their experience over the past month
from 0 to 10 for pain (average and worst), fatigue, and
restfulness of sleep using numerical rating scales (NRSs).
Finally, clinicians indicated health conditions addressed
during the visit and services received onsite (31 categories of
services were listed in the survey). Descriptive labels of services
were agreed upon by BraveNet investigators, drawing from
Eisenberg et al11,32 and National Health Interview Survey
CAM definitions.33,34
Statistical Analyses
All descriptive statistics were calculated using SAS version
9.4 and JMP Pro version 11.0 (SAS Institute, Inc., Cary, NC).
Categorical variables were summarized using frequencies and
percentages. Means and SDs were reported for continuous
variables. Univariate analyses were utilized to detect outliers,
which were subsequently submitted as queries to sites to
ensure clean data. Age values were calculated from birthdate
to visit date, and those below 18 years that could not be
validated by the sites were excluded from subsequent descrip-
tive analyses.RESULTS
Demographics and Patient Status
Of 4182 participants, the majority were non-Hispanic white
(84.5%) women (73.4%), with a mean age of 51.6 (SD ¼ 15.1)
years (Table 1). Patients were mostly self-referred (70%);
88.3% had health insurance, although the range of patients
planning to submit for insurance reimbursement varied
widely according to site (7–95%).
Perceived Stress, Symptoms of Depression, and Quality of
Life per Patient Report
Average PSS-4 scores were 5.9 (SD ¼ 3.29), a half-SD above
the national mean (Table 2). In fact, 64% scored above the
national mean for individuals with similar socioeconomic
status, and 20% of the sample was more than two SDs
above. Average CESD scores were 8.9 (SD ¼ 6.15), one point
below the cutoff suggestive of likely clinical depression.29
More importantly, 39% scored Z10, suggesting likely
clinical depression. The average SF-12 mental-health score
was 44.1 (SD ¼ 11.19), a little more than a half-SD below the
national norm (mean ¼ 50, SD ¼ 9.5). The average
SF-12 physical-health score was 43.1 (SD ¼ 10.09), three-
fourths of an SD below the national norm (mean ¼ 50,
SD ¼ 9.6).
Pain, Sleep Quality, and Fatigue per Patient Report
Worst pain over the past month was rated at 5.2 (SD ¼ 3.11)
(0 ¼ no pain, 10 ¼ worst-imaginable pain), and average pain
Table 1. Demographics (n ¼ 4182)
Female (%) 73.4
Caucasian (%) 84.5
Hispanic (%) 8.8
Age (years), mean (SD) 51.6 (15.1)
Income 4 $100,000 (%) 42.3
College or graduate degrees (%) 72.7
Marital status (%)
Married 53.7
Single 22.8
Divorced/separated 13.6
Have insurance (%) 88.3
Plan to use insurance 57.8
Table 3. Percentage of all IM Patients (n ¼ 4182) Presenting With
Psychological Conditions as Reported by Practitioners
All pain conditions 42.8
Fatigue 10.2
Stress 9.3
Anxiety 7.7
Depression 7.2
Sleep disorder 5.2was rated at 3.5 (SD ¼ 2.54). How rested participants felt
within the first hour upon waking over the past month was
rated at 5.8 (SD ¼ 2.54) (0 ¼ not at all, 10 ¼ very rested).
Overall fatigue experienced throughout the day in the past
month was indicated as 5.0 (SD ¼ 2.38) (0 ¼ none, 10 ¼
worst). The two latter scales were positively skewed, with 58%
and 57% of the sample reporting scores above the
group mean.
Psychological Issues per Provider Report
Common psychological conditions (not mutually exclusive)
addressed during visits included pain (43%, combining all
pain-related conditions), fatigue (10%), stress (9%), anxiety
(8%), depression (7%), and sleep difficulty (5%) (Table 3).12
Of 4182 patients, providers identified 2526 (60%) as having at
least one of the following: chronic or acute pain, fatigue,
stress, anxiety, depression, or a sleep disorder. Of these 2526
patients, the percentages with psychological issues and/or
pain were understandably higher than those in the entire
patient cohort, although they reflected the same pattern: pain
(56%, combining all pain-related conditions), fatigue (12%),
stress (11%), anxiety (9%), depression (7%), and sleep diffi-
culty (5%). Differences between the overall and psychological
cohorts are shown in Table 2.
Services Received
Percentages of the psychological cohort receiving or partic-
ipating in each therapeutic modality are listed in Table 4:Table 2. Comparison of Means of Psychosocial and Non-Psychosocial
Score Overall (n ¼ 4182) Psychosocial Cohort (n ¼
Mean SD Mean
CESD 8.93 6.15 9.65 6
PSS-4 5.93 3.29 6.28 3
SF-12 mental 44.09 11.19 43.21 11
SF-12 physical 43.12 10.09 41.28 10
Worst pain 5.21 3.11 5.89 2
Average pain 3.52 2.54 4.01 2
Fatigue 4.99 2.38 5.27 2
Quality-of-sleep 5.84 2.54 5.58 2acupuncture, 29.3%; IM physician consultations, 24.3%;
diet/nutritional counseling, 19.6%; exercise consults, 7.5%;
and chiropractic care, 6.7%.Relationship between psychological conditions and services
received. To display which services were used to treat which
psychological issues, Figure 1 shows the cross-reference
between (1) psychological conditions addressed at the IM
visit for at least 2% of the psychological cohort of n ¼ 2526,
and (2) the specific IM services received by at least 2% of the
cohort. The x-axis includes a “bar” per psychological con-
dition where the width of the bar indicates the proportions of
services utilized by the cohort with the specified condition
addressed at their IM visit. Conditions are listed from left to
right on the x-axis in order of proportion. For example,
chronic pain was the most-frequent condition addressed and
therefore is represented by the widest “bar.” In contrast, sleep
disorders were the least frequent (5.0%). The y-axis represents
a breakdown of the types of services received per condition
report. The indicator bar to the far left of the plot provides
color-coding for each service as well as the overall proportion
of each service provided. For instance, acupuncture is color-
coded as magenta and constituted the largest portion of the
services provided across all conditions (24.0%). In contrast,
energy therapy is color-coded as green and was the least-
received service (2.2%). Within each condition “bar” is shown
the proportion of services received by patients utilizing a
specific modality. So among services provided for chronic
pain, for example, nearly 40% were acupuncture, approxi-
mately 12% were IM consults, and so forth. Interestingly,
among all conditions involving pain, acupuncture was the
most frequently received service, whereas stress and fatigue
were treated with greater proportions of IM consultation andCohort via Wilcoxon Signed-Rank Test
2526) Non-Psychosocial Cohort (n ¼ 1656) P Value
SD Mean SD
.25 7.84 5.84 o.0001
.26 5.39 3.25 o.0001
.32 45.48 10.86 o.0001
.16 46.00 9.29 o.0001
.92 4.17 3.11 o.0001
.48 2.75 2.44 o.0001
.34 4.57 2.38 o.0001
.56 6.23 2.47 o.0001
Table 4. Percentage of IM Patients with Psychological Conditions
(n ¼ 2526) Receiving a Given Service
%
Acupuncture 29.3
IM consultation 24.3
Diet/nutritional counseling 19.6
Exercise consultation 7.5
Chiropractic 6.7
Non-vitamin supplements 5.9
Massage Therapy 5.0
Osteopathy 4.9
Mind–Body Therapy 4.9
Energy 2.9
Psychotherapy 2.8diet/nutritional counseling. Patients with anxiety, depression,
and/or sleep disorders were treated with IM consultation and
relatively similar levels of acupuncture and diet/nutritional
counseling.DISCUSSION
There were two major findings. First, an astounding 60% of
IM patients were treated for high stress, a psychological
condition, or pain. Patient-reported outcomes supported this
finding, documenting higher levels of perceived stress andFigure 1. Mosaic plot. A graphical summary of the proportion of service
y-Axis indicates the proportion of services utilized for each psychologic
proportion and color-coding of each service.depressive symptoms and lower quality of life relative to
national norms. They also showed more pain, poorer sleep
quality, and greater fatigue than comparison groups from the
literature. Second, this systematic data collection allows us to
characterize the IM treatments most frequently offered for
patients with stress and other psychological issues.35
Stress, Depression, and Quality of Life
Despite geographical differences, remarkable similarities were
seen across sites in psychological patient-reported outcomes
of the entire IM cohort. Perceived stress was consistently high
in our population (mean ¼ 5.9, SD ¼ 3.29) compared with
national norms. This was true for all patients together and for
each of the nine sites. BraveNet patients noted stress levels
half an SD above national norms. Moreover, 20% reported
stress levels that exceeded two SDs above the normative
mean. In other words, 20% of IM patients were as stressed as
the top 2.3% of the regular population. In addition, IM
patients reported greater levels of stress compared with other
medical populations.36,37 Since women typically report
higher levels of stress than men,38 the higher percentage of
women in our sample might contribute to this presentation.
However, this is clearly not the whole explanation; three
national surveys using the PSS-10 consistently found that
stress decreased with increasing age, education, and income,
and was lower for whites.38 With this highly educated, fairly
affluent, mostly white sample, lower stress levels would have
been expected.
For depressive symptoms, the IM patients as a group did
not meet the established criterion of 9.0 for symptoms ofs provided for specified conditions addressed at IM visit (x-axis).
al condition subgroup. The indicator bar represents the overall
moderate clinical depression.29 More importantly, though,
39% scored in the range indicative of likely moderate
depression, which is quite high compared with the 12.2%
prevalence of depression in other studies of medical
outpatients.39 IM patient scores were generally comparable
to those of different groups of chronic medical patients.40–43
IM patient scores on the CESD were higher than those of
patients in hemodialysis,44 those with limb loss,45 and those
of elderly individuals.46–49
For quality of life, our population exhibited mental and
physical scores half to three-fourths of an SD below the
national mean,31 but scores were consistent with reports of
other IM patient groups. This is similar to subsets of IM
patients with asthma50 and in general patients seeking IM.51,52
Pain, Sleep Quality, and Fatigue
While there are no normative samples available for 0–10
NRSs to compare reports on pain, sleep quality, and fatigue,
BraveNet outcomes can be compared with NRS reports from
previous studies. Our patients reported an average of 5.2 (SD
¼ 3.11) for worst pain and 3.5 (SD ¼ 2.54) for average pain.
Higher ratings have been seen in other groups seeking IM for
pain. For example, a study of 521 patients with low back pain
reported an 8.5 rating of worst pain and a 5.4 rating of average
pain53 and those seeking CAM interventions for herpes zoster
and post-herpetic neuralgia reported average pain levels of
7.5–7.8.54 The lower pain profiles in our sample likely relate
to inclusion of patients seeking IM for prevention, overall
wellness, and chronic health conditions not associated with
pain. We know that chronic-pain patients seeking IM in these
same clinics have averaged 4.7 on the same scale prior to
treatment.25
For sleep quality, there is a single study available to
compare with our sample. Chinese patients, older than 90
years and without dementia, averaged 5.2 on a similar scale
(SD ¼ 2.555). The mean age of our sample was significantly
younger, and sleep quality averaged 5.8 (SD ¼ 2.54).
For fatigue, BraveNet patients reported levels averaging 5.0
(SD ¼ 2.38), indicating less fatigue than those with chronic
fatigue syndrome (mean ¼ 6.8, SD ¼ 1.656), but greater
fatigue than seen in cancer patients (mean range from 2.5 to
4.757–60).
While this is the first large-scale report of the psychological
profile of IM patients across multiple clinics, our findings are
consistent with reports from individual IM clinics. In a recent
review of 29 clinics, 75% reported clinical success with
chronic pain, 55% with depression/anxiety, 52% with stress,
and 48% with fatigue/sleep disorders. These were among the
top conditions for which IM clinicians reported greatest
clinical success.5
Relevance to Clinical Care
High rates of pain, fatigue, depression, and stress-related
disorders, and significant accompanying morbidity make
development of successful treatment approaches a high prior-
ity. Chronic pain impacts more American adults than those
who are affected by heart disease, cancer, and diabetes
combined at a cost between $560 billion and $635 billion
annually.61 Similarly, major depressive disorder affects 10–20% of the US population and is the leading cause of
disability and significant healthcare costs.62,63 The prevalence
of clinically significant fatigue ranges from 5% to 20% in the
general population, depending on the threshold for severity
and persistence with survey reports.64
In addition, substantial concern exists regarding conven-
tional treatments. Medications used to treat chronic pain have
adverse side effects and/or high addictive potential, and
patients frequently develop tolerance. Likewise, anxiolytics
and hypnotics are often prescribed for hyperarousal after
significant stressors and are potentially addictive.19 First-line
treatments for depression typically consist of cognitive-
behavioral therapy or serotonin reuptake inhibitors; the latter
can have gastrointestinal and sexual dysfunction side effects.65
Furthermore, 37% of patients with depression do not receive
treatment; of those who do, 60% aged o64 years discontinue
treatment in the first 6 months.66 Recurrence rates range from
40% to 85%.67,68 Similarly, treatment of fatigue has chal-
lenges because it is a nonspecific symptom, and the mecha-
nisms underlying it are poorly understood. One longitudinal
study of primary-care patients reporting fatigue found that
half did not receive any diagnosis that could explain fatigue.69
Lack of explanation and understanding of mechanism leads
to difficulty in choosing an appropriate conventional therapy
for the provider.
Given the challenges of conventional treatments for psy-
chological and pain conditions, it is understandable that
individuals seek IM. Moreover, evidence demonstrating IM's
effectiveness continues to accumulate. Acupuncture and
mind–body treatments like meditation now have demon-
strated efficacy and effectiveness for many psychological
issues, including stress, depression, low quality of life, and
pain (acupuncture70–73 and meditation74–77). Moreover, the
importance of lifestyle change is burgeoning.78–80
Treatment Received
While IM emphasizes individually tailored treatments,
modalities tend to be similar across sites for specific psycho-
logical issues (Figure 1). In contrast to earlier reports,33 our
participants most often received combinations of
acupuncture, IM consult, diet/nutrition counseling, exercise
consultation, and chiropractic services.
Limitations and Next Steps
First, given the sample heterogeneity, assessment of psycho-
logical features may be diluted. Additionally, comparisons
with other populations must be made conservatively. Pro-
spective, longitudinal, and comparative-effectiveness trials are
needed to better understand the effectiveness of IM
approaches. Nevertheless, systematic data-collection proce-
dures within this PBRN represent a significant step toward the
ability to characterize how psychological profiles of IM
patients change over time.CONCLUSION
IM focuses on a holistic approach to optimizing health by
blending evidence-based Eastern and Western practices into
patient-centered care. While patient interest and use has
increased, the literature on clinical practice of IM has been
limited. This is the first large-scale study describing psycho-
logical profiles and therapies received across a national network
of IM clinics. Despite subtle demographic differences across
our clinics, patients seeking IM care demonstrated remarkably
similar psychological characteristics, including high stress
levels, elevated pain, significant fatigue, moderate depressive
symptoms, reduced quality of life, and poor sleep quality. The
most common therapies received were acupuncture, IM con-
sultation, diet/nutrition counseling, exercise consultation, and
chiropractic care. These findings set the stage for future PBRN
studies to examine promising interventions for stress and other
psychological conditions in IM patients.APPENDIX A SUPPLEMENTARY MATERIAL 
Supplementary data associated with this article can be found 
in the online version at 
2015.04.003.
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